BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 10623811)

  • 1. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.
    Evans DE; Munks MW; Purkerson JM; Parker DC
    J Immunol; 2000 Jan; 164(2):688-97. PubMed ID: 10623811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
    Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
    J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
    Jaiswal AI; Dubey C; Swain SL; Croft M
    Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.
    Shirota H; Sano K; Hirasawa N; Terui T; Ohuchi K; Hattori T; Tamura G
    J Immunol; 2002 Jul; 169(2):787-94. PubMed ID: 12097381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
    Clatza A; Bonifaz LC; Vignali DA; Moreno J
    J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A.
    Eshima K; Choi Y; Flavell RA
    Int Immunol; 2003 Jul; 15(7):817-26. PubMed ID: 12807820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of CD80 (B7-1) by T cells.
    Sabzevari H; Kantor J; Jaigirdar A; Tagaya Y; Naramura M; Hodge J; Bernon J; Schlom J
    J Immunol; 2001 Feb; 166(4):2505-13. PubMed ID: 11160311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell.
    Kasprowicz DJ; Kohm AP; Berton MT; Chruscinski AJ; Sharpe A; Sanders VM
    J Immunol; 2000 Jul; 165(2):680-90. PubMed ID: 10878340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
    Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
    Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD; Kruisbeek AM
    Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.
    Buhlmann JE; Elkin SK; Sharpe AH
    J Immunol; 2003 Jun; 170(11):5421-8. PubMed ID: 12759417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.
    Gaglia JL; Greenfield EA; Mattoo A; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 2000 Dec; 165(11):6091-8. PubMed ID: 11086041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells.
    Nakae S; Asano M; Horai R; Sakaguchi N; Iwakura Y
    J Immunol; 2001 Jul; 167(1):90-7. PubMed ID: 11418636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL.
    Prilliman KR; Lemmens EE; Palioungas G; Wolfe TG; Allison JP; Sharpe AH; Schoenberger SP
    J Immunol; 2002 Oct; 169(8):4094-7. PubMed ID: 12370335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.